This site is intended for health professionals only

Pulse Today At the heart of general practice since 1960
The agony of A&G

The agony of A&G

Read the latest issue online

Sign inRegister

Home - Sponsored - AZ See Beyond Sugar Hub

This is a promotional web page developed and funded by AstraZeneca for UK healthcare professionals only.

Clinical expert and patient perspective

The FORXIGA® (Dapagliflozin) prescribing information is available via the tabs throughout the site. Adverse event reporting information can be found at the bottom of this page.

Clinical expert and patient perspective

Watch the experts discussing the impact of the latest NICE type 2 diabetes guideline (CPD-certified)

Episode 1: Are you considering cardiovascular risk in type 2 diabetes?

Dr Kevin Fernando and Judy Winter discuss:

1. How the NICE type 2 diabetes guideline has evolved

2. The case for shifting towards a cardiovascular risk-based approach for people living with type 2 diabetes

Episode 2: NICE type 2 diabetes guideline – what’s changed?

Dr Kevin Fernando and Judy Winter discuss:

1. The updated NICE type 2 diabetes treatment recommendations for managing cardiovascular risk

2. How these recommendations could affect clinical practice

Episode 3: Implementing the NICE
type 2 diabetes guideline

Dr Kevin Fernando and Judy Winter discuss:

1. How to practically search and review patients with type 2 diabetes

2. How to risk stratify patients based on cardiovascular risk

Impact on your patients – Follow Ian’s Journey

Follow Ian on his type 2 diabetes journey and reflect on the potential implications a cardiovascular risk based-approach could have on people living with type 2 diabetes. Listen to Ian’s perspective on his type 2 diabetes by choosing between two different hypothetical scenarios, one in which Ian’s cardiovascular risk is managed and one in which it is not.

Following the viewing of these videos, on a scale of 1–5, how likely are you to implement a NICE-recommended cardiovascular risk-based approach into your clinical type 2 diabetes practice?

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AstraZeneca by visiting https://aereporting.astrazeneca.com or by calling 0800 783 0033.

GB-45539

June 2023

Content developed and funded by

Sign up for news alerts and don't miss out

Subscribe to Pulse's newsletters to ensure you receive the news as it happens.

  • Pulse Daily
  • Pulse Weekly
  • Pulse Views
  • Pulse Clinical
  • Pulse Practice Jobs
  • PCN Newsletter
Register now

Sharpen your skills and further your career with Pulse

Other links

Other Cogora brands

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora